AAPG
ASCENTAGE PHARMA GROUP INTERNATIONAL
NASDAQ · Healthcare · Biotechnology · CN
$17.62
+1.47%Year over year
Reported trailing growth
- Revenue
- -11.0%
- EBITDA
- —
- EBIT
- —
- EPS
- +61.3%
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- +177.8%
- EBITDA
- +95.2%
- EPS
- +82.2%
Three-year CAGR
- Revenue
- +38.6%
- EBITDA
- —
- EBIT
- —
- Net income
- —
- EPS
- —
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026